Navigation Links
Hoosier Oncology Group Selects OnCore to Support Clinical Trials Network
Date:8/7/2013

MADISON, Wis. and INDIANAPOLIS, Aug. 7, 2013 /PRNewswire/ -- Forte Research Systems, developer of specialized clinical research software, and the Hoosier Oncology Group ("the HOG"), a leading not-for-profit company specializing in the management of investigator-initiated clinical trials, are pleased to announce that HOG has selected Forte's OnCore® Enterprise Research system to support the trials of the newly formed Big Ten Cancer Research Consortium, as well as the HOG's additional portfolio of clinical trials.

(Logo: http://photos.prnewswire.com/prnh/20101115/CG02078LOGO)

The HOG will use functionality within OnCore to streamline the administration of trials, including financials management and electronic data capture, across its network.

Collaboration in Oncology Clinical Trials
The HOG supports more than 400 research center physicians and practitioners throughout its network. It is also the administrative headquarters of the Big Ten Cancer Research Consortium, a network consisting of 12 academic cancer centers and research universities that have come together to collaborate and conduct highly translational oncology trials.

Officially launched in June, the new consortium leverages its members' collective expertise and streamlines the process of conducting trials. Through their combined efforts, the centers have access to more than 30,000 new patients each year.  

"The Big Ten Cancer Research Consortium is a new collaborative endeavor that has been created to transform the way oncology trials are conducted," said Tim Breen, Data Systems Director at the HOG. "It was important to select the right system to accomplish these goals, and we decided that the OnCore system was the best solution."

Srini Kalluri, Founder, CEO, and Chief Customer Officer at Forte, believes the selection of OnCore to support the consortium represents an opportunity to enhance existing relationships with institutions while building new ones. "We are pleased to have already been working with more than half of the institutions in the Big Ten Cancer Research Consortium, and we are excited to expand our support to the other institutions involved," he said. "The collaboration is an exciting new endeavor in clinical research, and we are thrilled to be a part of it."  

About Forte Research Systems, Inc.
Founded in 2000 and headquartered in Madison, Wisconsin, Forte Research Systems, Inc. develops and markets clinical and translational research software for better research compliance, patient safety, operational efficiency, and financial viability. The company's flagship product, the OnCore® Enterprise Research solution, has been meeting the needs of academic medical centers, CTSAs, research hospitals, and cancer centers for over a dozen years. Now, its proven electronic data capture platform is available as a stand-alone hosted solution for academic researchers, Overture™ EDC. For Research Sites, Site Networks, and SMOs, Forte offers Allegro® CTMS. Forte is also host to the Clinical Research Blog and other resources for individuals interested in excellence in clinical research operations.

About Hoosier Oncology Group
The Hoosier Oncology Group, Inc. (affectionately nicknamed "the HOG") consists of a working association of over 400 dedicated community and research center physicians and clinical research practitioners. The HOG is committed to improving therapy for cancer patients through clinical research throughout its network.


'/>"/>
SOURCE Forte Research Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Orfit Launches Open Face Hybrid Mask For Patient Immobilization In Radiation Oncology
2. Life Technologies and RainTree Oncology Services Announce Collaboration to Bring Molecular Tumor Testing to Community Oncologists
3. Astellas Appoints New Senior Vice President of Global Oncology Development
4. Oncology remains most restrictive specialty for second year
5. Using Success & Failure Roadmap Paves the Way for Positive New Product Launches in Oncology
6. Accelovance Primed to Achieve Leadership in Oncology Clinical Trials
7. Loxo Oncology And Array BioPharma Announce License And Collaboration Agreement
8. Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Base
9. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
10. PRISM Pharma Closes $15 million Series C Financing to Advance PRI-724 into Non-oncology Indications
11. Sorrento Therapeutics Receives Frost & Sullivans Prestigious 2013 Global Investment Opportunity Award in the Oncology Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016   Bernstein Liebhard LLP ... filed in the United States District Court for the District ... class (the "Class") consisting of all persons or entities who ... "Company") (NASDAQ: INSY ) from March 3, 2015 through ... and certain of its officers with violations of the Securities ...
(Date:2/4/2016)... 4, 2016  Montoya Love is recognized by Continental ... of Pharmaceuticals. Montoya is the Regulatory Systems Operations Manager ... Manufacturing and selling a broad ... provides healthcare institutions, clinical laboratories and life science ... across the globe. ...
(Date:2/4/2016)... 2016 Frontier Pharma: Chronic Obstructive Pulmonary ... Chronic Obstructive Pulmonary Disease (COPD) ... of the airways and lungs. Persistent breathing difficulties ... disease one of the leading causes of morbidity ... world. COPD is linked to cumulative exposure to ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Looking for a last-minute Valentine’s ... the tips of your toes. Foot massage, whether administered by a professional masseuse or ... relaxation. The American Board of Multiple Specialties in Podiatry (ABMSP) has taken ...
(Date:2/5/2016)... Rafael, CA (PRWEB) , ... February 05, 2016 , ... ... with ChildLight Yoga Studio in Dover, NH to direct high-performance kids yoga training. ChildLight ... New Hampshire’s seacoast, just one hour from Boston. , ChildLight Yoga Studio founder Lisa ...
(Date:2/5/2016)... ... 05, 2016 , ... Give To Cure today announced that it ... to Give To Cure’s campaign that is crowdfunding clinical trials to help find cures ... payments through a smart device. In 2015 alone, Venmo processed $7.5 billion in transactions ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Dr. Justin ... announce their 2nd Annual No Cost Dental Day to individuals in need. The event ... purpose of this No Cost Dental Day is to provide dental care to community ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... In sleep, ... form as a dream. A hallmark feature of patients with eating disorders is significant ... The eating disorder behaviors and obsessions are regarded as maladaptive means for coping with ...
Breaking Medicine News(10 mins):